Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 21;7(11):ofaa507.
doi: 10.1093/ofid/ofaa507. eCollection 2020 Nov.

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019

Yusuke Miyazato  1 , Shinichiro Morioka  1   2   3 , Shinya Tsuzuki  3   4 , Masako Akashi  1 , Yasuyo Osanai  1 , Keiko Tanaka  1 , Mari Terada  1 , Michiyo Suzuki  1 , Satoshi Kutsuna  1 , Sho Saito  1   2 , Kayoko Hayakawa  1   3 , Norio Ohmagari  1   3
Affiliations

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019

Yusuke Miyazato et al. Open Forum Infect Dis. .

Abstract

Some patients who recover from coronavirus disease 2019 (COVID-19) have prolonged symptoms such as dyspnea, fatigue, cough, and dysosmia for longer than 120 days after symptom onset. In addition, some patients who recovered from COVID-19 reported hair loss a few months after the onset of the disease. Alopecia is a late-onset symptom of COVID-19. The cause of alopecia is unknown; however, androgenic alopecia and telogen effluvium are possible causes.

Keywords: COVID-19; alopecia; duration; late-onset symptoms; prolonged symptoms.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of patients who presented symptoms after admission (n = 63).
Figure 2.
Figure 2.
Proportion of patients who presented alopecia after admission (n = 58).
See this image and copyright information in PMC

References

    1. Tenforde MW, Kim SS, Lindsell CJ, et al. ; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69:993–8. - PMC - PubMed
    1. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324:603–5. - PMC - PubMed
    1. Wambier CG, Vaño-Galván S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the “Gabrin sign”. J Am Acad Dermatol 2020; 83:680–2. - PMC - PubMed
    1. Miguel D, Lara H, Diego F, et al. Acute telogen effluvium associated with SARS-CoV-2 infection. Aust J Gen Pract 2020; 49Suppl 32. doi: 10.31128/AJGP-COVID-32. - DOI - PubMed
    1. Tiffany A, Vetter P, Mattia J, et al. Ebola virus disease complications as experienced by survivors in Sierra Leone. Clin Infect Dis 2016; 62:1360–6. - PMC - PubMed